{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=0.005%25+latanoprost&page=3", "query": { "intervention": "0.005% latanoprost", "page": 3 }, "page_size": 10 }, "pagination": { "page": 3, "page_size": 10, "total_count": 79, "total_pages": 8, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=0.005%25+latanoprost&page=4&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=0.005%25+latanoprost&page=2&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-03T20:46:29.994Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT02558400", "title": "Double-masked Study of PG324 Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Open-angle Glaucoma", "Ocular Hypertension" ], "interventions": [ { "name": "PG324 Ophthalmic Solution 0.02%/0.005%", "type": "DRUG" }, { "name": "Netarsudil (AR-13324) Ophthalmic Solution 0.02%", "type": "DRUG" }, { "name": "Latanoprost Ophthalmic Solution 0.005%", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Aerie Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 718, "start_date": "2015-09-18", "completion_date": "2017-06-30", "has_results": true, "last_update_posted_date": "2019-06-04", "last_synced_at": "2026-10-03T20:46:29.994Z", "location_count": 1, "location_summary": "Bedminster, New Jersey", "locations": [ { "city": "Bedminster", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT02558400" }, { "nct_id": "NCT03949244", "title": "Nailfold Capillary Blood Flow With Latanoprost Bunod", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Glaucoma, Open-Angle" ], "interventions": [ { "name": "Latanoprost 0.005%", "type": "DRUG" }, { "name": "Latanoprost bunod 0.024%", "type": "DRUG" }, { "name": "Normal saline 0.9%", "type": "DRUG" }, { "name": "Nailfold capillaroscopy", "type": "DIAGNOSTIC_TEST" } ], "intervention_types": [ "DRUG", "DIAGNOSTIC_TEST" ], "sponsor": "Icahn School of Medicine at Mount Sinai", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "40 Years to 80 Years" }, "enrollment_count": 47, "start_date": "2019-08-15", "completion_date": "2020-10-01", "has_results": true, "last_update_posted_date": "2021-09-29", "last_synced_at": "2026-10-03T20:46:29.994Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT03949244" }, { "nct_id": "NCT00846989", "title": "Efficacy, Tolerability and Safety of RKI983 (0.05% & 0.10%) vs Xalatan in Patients With POAG or Ocular Hypertension", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Glaucoma", "Ocular Hypertension" ], "interventions": [ { "name": "RKI983A", "type": "DRUG" }, { "name": "Latanoprost", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novartis Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "MALE", "summary": "18 Years and older · Male only" }, "enrollment_count": 276, "start_date": "2009-01", "completion_date": "2009-04", "has_results": false, "last_update_posted_date": "2020-12-19", "last_synced_at": "2026-10-03T20:46:29.994Z", "location_count": 29, "location_summary": "Artesia, California • Inglewood, California • La Jolla, California + 25 more", "locations": [ { "city": "Artesia", "state": "California" }, { "city": "Inglewood", "state": "California" }, { "city": "La Jolla", "state": "California" }, { "city": "Poway", "state": "California" }, { "city": "Stockton", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00846989" }, { "nct_id": "NCT07082816", "title": "Reformulated PG324 Ophthalmic Solution for Intraocular Pressure Reduction", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Ocular Hypertension", "Open Angle Glaucoma" ], "interventions": [ { "name": "Netarsudil 0.01%/latanoprost 0.005% ophthalmic solution", "type": "DRUG" }, { "name": "Netarsudil 0.02%/latanoprost 0.005% ophthalmic solution", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Alcon Research", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 489, "start_date": "2025-09-02", "completion_date": "2026-04-06", "has_results": false, "last_update_posted_date": "2026-04-21", "last_synced_at": "2026-10-03T20:46:29.994Z", "location_count": 30, "location_summary": "Dothan, Alabama • Phoenix, Arizona • Garden Grove, California + 25 more", "locations": [ { "city": "Dothan", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Garden Grove", "state": "California" }, { "city": "Inglewood", "state": "California" }, { "city": "Newport Beach", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT07082816" }, { "nct_id": "NCT00868894", "title": "Safety and Efficacy Study of DE-104 Ophthalmic Solution to Treat Open-angle Glaucoma or Ocular Hypertension", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Open-Angle Glaucoma", "Ocular Hypertension" ], "interventions": [ { "name": "DE-104 medium concentration", "type": "DRUG" }, { "name": "DE-104 high concentration", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "0.005% latanoprost", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Santen Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 49, "start_date": "2009-03", "completion_date": "2010-06", "has_results": false, "last_update_posted_date": "2011-11-03", "last_synced_at": "2026-10-03T20:46:29.994Z", "location_count": 6, "location_summary": "Artesia, California • Pasadena, California • San Francisco, California + 3 more", "locations": [ { "city": "Artesia", "state": "California" }, { "city": "Pasadena", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "Honolulu", "state": "Hawaii" }, { "city": "Kailua", "state": "Hawaii" } ], "official_url": "https://clinicaltrials.gov/study/NCT00868894" }, { "nct_id": "NCT01254370", "title": "Safety and Efficacy Study of Catioprost® (Unpreserved Latanoprost 0.005% Emulsion) Compared to Travatan Z® to Treat Glaucoma and Ocular Surface Disease", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Glaucoma", "Ocular Hypertension", "Ocular Surface Disease" ], "interventions": [ { "name": "Latanoprost", "type": "DRUG" }, { "name": "Travatan Z", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Santen SAS", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 105, "start_date": "2010-11", "completion_date": "2011-06", "has_results": false, "last_update_posted_date": "2016-06-06", "last_synced_at": "2026-10-03T20:46:29.994Z", "location_count": 1, "location_summary": "Andover, Massachusetts", "locations": [ { "city": "Andover", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT01254370" }, { "nct_id": "NCT05165290", "title": "Prospective, Double-masked, Randomized, Multi-center, Active-controlled, Parallel-group, 3-month Study Assessing the Safety & Ocular Hypotensive Efficacy of TC-002 Ophthalmic Solution Compared to Latanoprost Ophthalmic Solution 0.005% in Subjects With Elevated Intraocular Pressure", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Elevated Intraocular Pressure" ], "interventions": [ { "name": "Latanoprost ophthalmic solution, 0.005%", "type": "DRUG" }, { "name": "TC-002 latanoprost ophthalmic solution, 0.005%", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "TearClear Corp", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 300, "start_date": "2021-11-29", "completion_date": "2022-09", "has_results": false, "last_update_posted_date": "2022-05-25", "last_synced_at": "2026-10-03T20:46:29.994Z", "location_count": 20, "location_summary": "Garden Grove, California • Glendale, California • Mission Hills, California + 16 more", "locations": [ { "city": "Garden Grove", "state": "California" }, { "city": "Glendale", "state": "California" }, { "city": "Mission Hills", "state": "California" }, { "city": "Newport Beach", "state": "California" }, { "city": "Petaluma", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT05165290" }, { "nct_id": "NCT01060579", "title": "Study of AR-12286 Versus Latanoprost in Patients With Elevated Intraocular Pressure", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Glaucoma" ], "interventions": [ { "name": "AR-12286 0.5% ophthalmic solution", "type": "DRUG" }, { "name": "AR-12286 0.25% Ophthalmic solution", "type": "DRUG" }, { "name": "Latanoprost ophthalmic solution", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Aerie Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 217, "start_date": "2010-02", "completion_date": "2010-08", "has_results": false, "last_update_posted_date": "2014-05-08", "last_synced_at": "2026-10-03T20:46:29.994Z", "location_count": 18, "location_summary": "Inglewood, California • Petaluma, California • Poway, California + 15 more", "locations": [ { "city": "Inglewood", "state": "California" }, { "city": "Petaluma", "state": "California" }, { "city": "Poway", "state": "California" }, { "city": "Stuart", "state": "Florida" }, { "city": "Tamarac", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT01060579" }, { "nct_id": "NCT00638742", "title": "A Phase 1, Open-Label Study of Latanoprost Acid Plasma Concentrations in Pediatric and Adult Glaucoma Patients Treated With Latanoprost.", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Glaucoma", "Ocular Hypertension" ], "interventions": [ { "name": "latanoprost", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer's Upjohn has merged with Mylan to form Viatris Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "0 Years", "maximum_age": null, "sex": "ALL", "summary": "0 Years and older" }, "enrollment_count": 47, "start_date": "2008-05", "completion_date": "2009-03", "has_results": false, "last_update_posted_date": "2021-02-02", "last_synced_at": "2026-10-03T20:46:29.994Z", "location_count": 6, "location_summary": "Artesia, California • Atlanta, Georgia • North Dartmouth, Massachusetts + 2 more", "locations": [ { "city": "Artesia", "state": "California" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "North Dartmouth", "state": "Massachusetts" }, { "city": "Minneapolis", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT00638742" }, { "nct_id": "NCT01253902", "title": "Ocular Surface Tolerability Study of Prostaglandin Analogues in Patients With Open-Angle Glaucoma or Ocular Hypertension", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Glaucoma, Open-Angle", "Ocular Hypertension" ], "interventions": [ { "name": "bimatoprost ophthalmic solution 0.01%", "type": "DRUG" }, { "name": "travoprost ophthalmic solution 0.004%", "type": "DRUG" }, { "name": "latanoprost ophthalmic solution 0.005%", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Allergan", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 164, "start_date": "2010-12", "completion_date": "2011-10", "has_results": true, "last_update_posted_date": "2012-11-07", "last_synced_at": "2026-10-03T20:46:29.994Z", "location_count": 1, "location_summary": "Rogers, Arkansas", "locations": [ { "city": "Rogers", "state": "Arkansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT01253902" } ] }